Evidence map›Paper›PMID 32416600›Full record

ArticleJournal of clinical virology : the official publication of the Pan American Society for Clinical Virology2020

Comparison of seven commercial RT-PCR diagnostic kits for COVID-19.

Puck B van Kasteren, Bas van der Veer, Sharon van den Brink, Lisa Wijsman, Jørgen de Jonge, Annemarie van den Brandt, Richard Molenkamp, Chantal B E M Reusken, Adam Meijer

Open access · hybridAbstract readComment
In one paragraph

Article in Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 276 papers.

0numbers the graph read from it
0cells of the map it votes in
276citing papers in PubMed
11.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

276 citing papers in PubMed, 488 citations in OpenAlex.

  1. The role of mouthwash sampling in SARS-CoV-2 diagnosis.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2021
    Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Detection ofBioanalysis · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Development of a Novel Nested-RT-LAMP Assay for the Rapid and Accurate Coronavirus Disease-2019 Diagnosis.The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2025
    Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Review

216 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Puck B van KasterenNational Institute for Public Health and the Environment, Center for Infectious Disease Control, A. van Leeuwenhoeklaan 9, 3721 MA, Bilthoven, the Netherlands.
Bas van der VeerNational Institute for Public Health and the Environment, Center for Infectious Disease Control, A. van Leeuwenhoeklaan 9, 3721 MA, Bilthoven, the Netherlands.
Sharon van den BrinkNational Institute for Public Health and the Environment, Center for Infectious Disease Control, A. van Leeuwenhoeklaan 9, 3721 MA, Bilthoven, the Netherlands.
Lisa WijsmanNational Institute for Public Health and the Environment, Center for Infectious Disease Control, A. van Leeuwenhoeklaan 9, 3721 MA, Bilthoven, the Netherlands.
Jørgen de JongeNational Institute for Public Health and the Environment, Center for Infectious Disease Control, A. van Leeuwenhoeklaan 9, 3721 MA, Bilthoven, the Netherlands.
Annemarie van den BrandtNational Institute for Public Health and the Environment, Center for Infectious Disease Control, A. van Leeuwenhoeklaan 9, 3721 MA, Bilthoven, the Netherlands.
Richard MolenkampErasmus Medical Center, Viroscience Department, 's Gravendijkwal 230, 3015 CE, Rotterdam, the Netherlands.
Chantal B E M ReuskenNational Institute for Public Health and the Environment, Center for Infectious Disease Control, A. van Leeuwenhoeklaan 9, 3721 MA, Bilthoven, the Netherlands.
Adam MeijerNational Institute for Public Health and the Environment, Center for Infectious Disease Control, A. van Leeuwenhoeklaan 9, 3721 MA, Bilthoven, the Netherlands. Electronic address: adam.meijer@rivm.nl.
National Institute for Public Health and the Environment · NLErasmus University Rotterdam · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The final months of 2019 witnessed the emergence of a novel coronavirus in the human population. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has since spread across the globe and is posing a major burden on society. Measures taken to reduce its spread critically depend on timely and accurate identification of virus-infected individuals by the most sensitive and specific method available, i.e. real-time reverse transcriptase PCR (RT-PCR). Many commercial kits have recently become available, but their performance has not yet been independently assessed. The aim of this study was to compare basic analytical and clinical performance of selected RT-PCR kits from seven different manufacturers (Altona Diagnostics, BGI, CerTest Biotec, KH Medical, PrimerDesign, R-Biopharm AG, and Seegene). We used serial dilutions of viral RNA to establish PCR efficiency and estimate the 95 % limit of detection (LOD95). Furthermore, we ran a panel of SARS-CoV-2-positive clinical samples (n = 13) for a preliminary evaluation of clinical sensitivity. Finally, we used clinical samples positive for non-coronavirus respiratory viral infections (n = 6) and a panel of RNA from related human coronaviruses to evaluate assay specificity. PCR efficiency was ≥96 % for all assays and the estimated LOD95 varied within a 6-fold range. Using clinical samples, we observed some variations in detection rate between kits. Importantly, none of the assays showed cross-reactivity with other respiratory (corona)viruses, except as expected for the SARS-CoV-1 E-gene. We conclude that all RT-PCR kits assessed in this study may be used for routine diagnostics of COVID-19 in patients by experienced molecular diagnostic laboratories.

Indexed as

CoronavirusCoronavirus InfectionsBetacoronavirusCOVID-19HumansPandemicsPneumonia, ViralReverse Transcriptase Polymerase Chain ReactionRNA-Directed DNA PolymeraseSARS-CoV-2RNA-Directed DNA PolymeraseCoronavirusCOVID-19In vitro diagnosticsnCoV-2019RT-PCRSARS-CoV-2

Identifiers

PMID32416600
PMCPMC7206434
OpenAlexW3020838251

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.